NEO

NeoGenomics, Inc. is a leading provider of cancer-focused diagnostics and testing services, with an extensive laboratory network across the United States, Europe, and Asia. Headquartered in Fort Myers, Florida, the company excels in advanced molecular and genomic testing solutions, empowering personalized treatment strategies that significantly improve patient outcomes. With a commitment to innovation and quality, NeoGenomics leverages cutting-edge technology and a wide range of diagnostic tests, establishing itself as an essential partner for healthcare providers dedicated to precision cancer care.